Maria L Espinosa
Overview
Explore the profile of Maria L Espinosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh I, Espinosa M, Lim H, Mohammad T
Arch Dermatol Res
. 2024 Oct;
316(9):668.
PMID: 39382722
There are significant psychosocial burdens in patients with hyperpigmentation, which emphasizes the importance of treatment. Current gold standard for treatment is hydroquinone; however, alternatives have been developed given the concern...
2.
LeWitt T, Walker C, Espinosa M, Chung C, Zhou X, Guitart J
J Am Acad Dermatol
. 2023 Mar;
89(1):e67.
PMID: 36948297
No abstract available.
3.
Guitart J, Mangold A, Martinez-Escala M, Walker C, Comfere N, Pulitzer M, et al.
JAMA Dermatol
. 2022 Aug;
158(10):1167-1174.
PMID: 36001337
Importance: There is a knowledge gap about subcutaneous panniculitis-like T-cell lymphoma (SPTCL) owing to its rarity and diagnostic difficulty, resulting in an absence of well-documented large case series published to...
4.
Nguyen M, LeWitt T, Pang Y, Bagnowski K, Espinosa M, Choi J, et al.
Arch Dermatol Res
. 2022 Jun;
315(2):275-278.
PMID: 35668201
Cutaneous T-cell lymphoma (CTCL) risk factors and associated quality of life are poorly understood. Previous studies of CTCL risk factors explored patient comorbidities and lifestyle exposures, but not in conjunction...
5.
Espinosa M, Walker C, Guitart J, Mhlaba J
Cutis
. 2022 Jun;
109(3):E3-E7.
PMID: 35659141
Although mycosis fungoides (MF) and Sézary syndrome (SS) commonly affect Black patients, dermatologic educational resources primarily describe the appearance of these conditions in lighter skin types. Skin of color (SoC)...
6.
Chung C, Espinosa M, Walker C, Choi J, Zhou X, LeWitt T, et al.
J Am Acad Dermatol
. 2022 Feb;
87(5):1140-1141.
PMID: 35167923
No abstract available.
7.
LeWitt T, Walker C, Espinosa M, Chung C, Zhou X, Guitart J
J Am Acad Dermatol
. 2021 Nov;
87(4):856-858.
PMID: 34757149
No abstract available.
8.
Espinosa M, Abad C, Kurtzman Y, Abdulla F
Front Oncol
. 2021 Jun;
11:605941.
PMID: 34123780
Treatment of head and neck cancers requires multidisciplinary collaboration to reduce morbidity and mortality associated with the tumor burden, as well as to preserve function of organs and structures. With...
9.
Walker C, Martinez-Escala M, Tan T, Espinosa M, Guitart J
J Cutan Pathol
. 2021 Mar;
48(10):1231-1238.
PMID: 33759218
Background: Primary cutaneous gamma-delta T-cell lymphoma (PCγδTCL) and primary cutaneous aggressive epidermotropic T-cell lymphomas (PCAETCL) are rare aggressive cytotoxic cutaneous lymphomas (CyCL) often difficult to diagnose. Histopathologically, PCAETCL and PCγδTCL...
10.
Walker C, Espinosa M, Mehta-Shah N, Pro B, Guitart J, Kuzel T
J Drugs Dermatol
. 2021 Mar;
20(3):349-350.
PMID: 33683074
The combination of Interferon-α-2b (IFN-α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1.